Can plasma bile salt, triglycerides, and apoA-V levels predict liver regeneration?

World Journal of Surgery

Volumn 36, Issue 12, 2012, Pages 2901-2908

  Hoekstra, Lisette T ^a   Van Lienden, Krijn P ^b   Schaap, Frank G ^b   Chamuleau, Rob A F M ^b   Bennink, Roel J ^b   Van Gulik, Thomas M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; BILE ACID; BIOLOGICAL MARKER; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD; COLORECTAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIVER; LIVER REGENERATION; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PORTAL VEIN; PREOPERATIVE CARE; RADIOGRAPHY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; APOLIPOPROTEINS A; BILE ACIDS AND SALTS; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; ORGAN SIZE; PORTAL VEIN; PREOPERATIVE CARE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES;

EID: 84877107884     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1770-2     Document Type: Article

References (38)

1. Abulkhir A, Limongelli P, Healey AJ et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247:49-57
2. Kusaka K, Imamura H, Tomiya T et al (2004) Factors affecting liver regeneration after right portal vein embolization. Hepatogastroenterology 51:532-535
3. Kusaka K, Imamura H, Tomiya T et al (2006) Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization. Dig Dis Sci 51:1404-1412
4. de Graaf W, van den Esschert JW, van Lienden KP et al (2009) Induction of tumor growth after preoperative portal vein embolization: is it a real problem? Ann Surg Oncol 16:423-430
5. Dong X, Zhao H, Ma X et al (2010) Reduction in bile acid pool causes delayed liver regeneration accompanied by down-regulated expression of FXR and c-Jun mRNA in rats. J Huazhong Univ Sci Technol Med Sci 30:55-60
6. Huang W, Ma K, Zhang J et al (2006) Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312:233-236
7. Makino I, Chijiiwa K, Fukushima K et al (1997) Cholesterol and bile acid metabolism after selective portal vein ligation. J Surg Res 68:91-98
8. Ueda J, Chijiiwa K, Nakano K et al (2002) Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin E-associated kinase activity. Surgery 131:564-573
9. Vos TA, Ros JE, Havinga R et al (1999) Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 29:1833-1839
10. Hayashi H, Beppu T, Sugita H et al (2009) Increase in the serum bile acid level predicts the effective hypertrophy of the nonembolized hepatic lobe after right portal vein embolization. World J Surg 33:1933-1940. doi:10.1007/s00268- 009-0111-6
11. Delahunty TJ, Rubinstein D (1970) Accumulation and release of triglycerides by rat liver following partial hepatectomy. J Lipid Res 11:536-543
12. Frank PG, Lisanti MP (2007) Caveolin-1 and liver regeneration: role in proliferation and lipogenesis. Cell Cycle 6:115-116
13. Newberry EP, Kennedy SM, Xie Y et al (2008) Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. Hepatology 48:1097-1105
14. Kluger M, Heeren J, Merkel M (2008) Apoprotein A-V: an important regulator of triglyceride metabolism. J Inherit Metab Dis 31:81-88
15. Nilsson SK, Heeren J, Olivecrona G et al (2011) Apolipoprotein A-V; a potent triglyceride reducer. Atherosclerosis 219:15-21
16. Vergoni AV, Scarano A, Bertolini A (1992) Pinacidil potentiates morphine analgesia. Life Sci 50:L135-L138
17. Avritscher R, De BT, Murthy R et al (2008) Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Intervent Radiol 25:132-145
18. Shoup M, Gonen M, D'Angelica M et al (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7:325-330
19. de Graaf W, van Lienden KP, Dinant S et al (2010) Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 14:369-378
20. de Graaf W, van Lienden KP, van den Esschert JW et al (2011) Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98:825-834
21. Dinant S, de Graaf W, Verwer BJ et al (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685-692
22. Vaessen SF, Schaap FG, Kuivenhoven JA et al (2006) Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study. J Lipid Res 47:2064-2070
23. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205-213
24. Marin JJ, Barbero ER, Herrera MC et al (1993) Bile acid-induced modifications in DNA synthesis by the regenerating perfused rat liver. Hepatology 18:1182-1192
25. Chen WD, Wang YD, Meng Z et al (2011) Nuclear bile acid receptor FXR in the hepatic regeneration. Biochim Biophys Acta 1812:888-892
26. Wang YD, Chen WD, Huang W (2008) FXR, a target for different diseases. Histol Histopathol 23:621-627
27. Forte TM, Shu X, Ryan RO (2009) The ins (cell) and outs (plasma) of apolipoprotein A-V. J Lipid Res 50(Suppl):S150-S155
28. van der Vliet HN, Sammels MG, Leegwater AC et al (2001) Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276:44512-44520
29. Azoulay D, Castaing D, Smail A et al (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480-486
30. Barbaro B, Di Stasi C, Nuzzo G et al (2003) Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 44:98-102
31. Elias D, De Baere T, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784-788
32. Hayashi S, Baba Y, Ueno K et al (2007) Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization. Acta Radiol 48:721-727
33. Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267-272
34. Mailey B, Truong C, Artinyan A et al (2009) Surgical resection of primary and metastatic hepatic malignancies following portal vein embolization. J Surg Oncol 100:184-190
35. Pamecha V, Levene A, Grillo F et al (2009) Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer 100:617-622
36. Ribero D, Abdalla EK, Madoff DC et al (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94:1386-1394
37. Treska V, Skalicky T, Sutnar A et al (2010) Portal vein branch embolization in patients with primary inoperable liver tumors. Rozhl Chir 89:456-460
38. Hoekstra LT, van Lienden KP, Doets A et al (2012) Tumor progression after preoperative portal vein embolization. Ann Surg [in press]